GISAID
GISAID (Global Initiative on Sharing All Influenza Data) is a global science initiative and primary source that provides open-access to genomic data of influenza viruses and the coronavirus responsible for the COVID-19 pandemic.
History[edit | edit source]
GISAID was launched in 2008, in response to the H5N1 avian influenza. It was established as a mechanism to share influenza data, following the reluctance of certain countries to share their data due to concerns about intellectual property rights.
Function[edit | edit source]
GISAID promotes the international sharing of all influenza virus sequences, related clinical and epidemiological data associated with human viruses, and geographical as well as species-specific data associated with avian and other animal viruses. GISAID does so by overcoming disincentives/hurdles that discourage or prevent sharing of influenza data.
Role in COVID-19 pandemic[edit | edit source]
During the COVID-19 pandemic, GISAID has played a crucial role in the global response. It has served as the primary source of genome sequences of SARS-CoV-2, the virus responsible for the disease, with laboratories around the world submitting their sequences to the database.
See also[edit | edit source]
References[edit | edit source]
External links[edit | edit source]
GISAID Resources | ||
---|---|---|
|
|
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Prab R. Tumpati, MD